Polymorphisms of apolipoprotein E and methylenetetrahydrofolate reductase in the Japanese population

Journal of Atherosclerosis and Thrombosis

Volumn 14, Issue 4, 2007, Pages 167-171

  Arai, Hidenori ^a   Yamamoto, Akira ^b   Matsuzawa, Yuji ^c   Saito, Yasushi ^d   Yamada, Nobuhiro ^e   Oikawa, Shinichi ^f   Mabuchi, Hiroshi ^g   Teramoto, Tamio ^h   Sasaki, Jun ⁱ   Nakaya, Noriaki ^j   Itakura, Hiroshige ^k   Ishikawa, Yuichi ^l   Ouchi, Yasuyoshi ^m   Horibe, Hiroshi ⁿ   Egashira, Tohru ^o   Hattori, Hiroaki ^o   Kita, Toru ^a  

^a KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

^c SUMITOMO HOSPITAL   (Japan)

^d CHIBA UNIVERSITY   (Japan)

^e UNIVERSITY OF TSUKUBA   (Japan)

^f NIPPON MEDICAL SCHOOL   (Japan)

^g KANAZAWA UNIVERSITY   (Japan)

^h TEIKYO UNIVERSITY   (Japan)

ⁱ INTERNATIONAL UNIVERSITY OF HEALTH AND WELFARE   (Japan)

^j Fussa Hospital   (Japan)

^k IBARAKI CHRISTIAN UNIVERSITY   (Japan)

^l KOBE UNIVERSITY   (Japan)

^m UNIVERSITY OF TOKYO   (Japan)

ⁿ Keisen Clinic   (Japan)

^o BMI Inc

more..

Author keywords

Apolipoprotein E; Homocysteine; Hyperlipidemia; MTHFR; Polymorphism

Indexed keywords

APOLIPOPROTEIN E; HOMOCYSTEINE; LIPID; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2);

ARTICLE; ASIAN; BLOOD; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; HUMAN; HYPERHOMOCYSTEINEMIA; HYPERLIPIDEMIA; INFORMATION PROCESSING; JAPAN; MALE; SEX RATIO; STATISTICS;

APOLIPOPROTEINS E; ASIAN CONTINENTAL ANCESTRY GROUP; DATA COLLECTION; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HOMOCYSTEINE; HUMANS; HYPERHOMOCYSTEINEMIA; HYPERLIPIDEMIAS; JAPAN; LIPIDS; MALE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); POLYMORPHISM, GENETIC; SEX DISTRIBUTION;

EID: 38449110340     PISSN: 13403478     EISSN: 18803873     Source Type: Journal    
DOI: 10.5551/jat.E499     Document Type: Article

References (17)

1. Curtiss LK and Boisvert WA: Apolipoprotein E and atherosclerosis. Curr Opin Lipidol, 2000; 11:243-251
2. Davignon J, Gregg RE, and Sing CF: Apolipoprotein E polymorphism and atherosclerosis. Arteriosclerosis, 1988; 8:1-21
3. Wa ng YL, McCredie RM, and Wilcken DE: Polymorphisms of the apolipoprotein E gene and severity of coronary artery disease defined by angiography. Arterioscler Thromb Vasc Biol, 1995; 15:1030-1034
4. Katzman R: Apolipoprotein E and Alzheimer's disease. Curr Opin Neurobiol, 1994; 4:703-707
5. Rall SC Jr. and Mahley RW: The role of apolipoprotein E genetic variants in lipoprotein disorders. J Intern Med, 1992; 231:653-659
6. Boushey CJ, Beresford SA, Omenn GS, and Motulsky AG: A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes. JAMA, 1995; 274:1049-1057
7. Graham IM, Daly LE, Refsum HM, Robinson K, Brattstrom LE, Ueland PM, Palma-Reis RJ, Boers GH, Sheahan RG, Israelsson B, Uiterwaal CS, Meleady R, McMaster D, Verhoef P, Witteman J, Rubba P, Bellet H, Wautrecht JC, de Valk HW, Sales Luis AC, Parrot-Rouland FM, Tan KS, Higgins I, Garcon D, and Andria G: Plasma homocysteine as a risk factor for vascular disease. The European Concerted Action Project. Jama, 1997; 277:1775-1781
8. Ou T, Yamakawa-Kobayashi K, Arinami T, Amemiya H, Fujiwara H, Kawata K, Saito M, Kikuchi S, Noguchi Y, Sugishita Y, and Hamaguchi H: Methylenetetrahydrofolate reductase and apolipoprotein E polymorphisms are independent risk factors for coronary heart disease in Japanese: a case-control study. Atherosclerosis, 1998; 137:23-28
9. Clarke R, Smith AD, Jobst KA, Refsum H, Sutton L, and Ueland PM: Folate, vitamin B12, and serum total homocysteine levels in confirmed Alzheimer disease. Arch Neurol, 1998; 55:1449-1455
10. Brattstrom L, Wilcken DE, Ohrvik J, and Brudin L: Common methylenetetrahydrofolate reductase gene mutation leads to hyperhomocysteinemia but not to vascular disease: the result of a meta-analysis. Circulation, 1998; 98:2520-2526
11. Shinomiya S, Sasaki J, Kiyohara C, Tsuji E, Inoue H, Marugame T, Handa K, Hayabuchi H, Hamada H, Eguchi H, Fukushima Y, and Kono S: Apolipoprotein E genotype, serum lipids, and colorectal adenomas in Japanese men. Cancer Lett, 2001; 164:33-40
12. Johnson CL, Rifkind BM, Sempos CT, Carroll MD, Bachorik PS, Briefel RR, Gordon DJ, Burt VL, Brown CD, Lippel K, and Cleeman JI: Declining serum total cholesterol levels among US adults. The National Health and Nutrition Examination Surveys. Jama, 1993; 269:3002-3008
13. Ubbink JB, Hayward Vermaak WJ, and Bissbort S: Rapid high-performance liquid chromatographic assay for total homocysteine levels in human serum. J Chromatogr, 1991; 565:441-446
14. Arai H, Yamamoto A, Matsuzawa Y, Saito Y, Yamada N, Oikawa S, Mabuchi H, Teramoto T, Sasaki J, Nakaya N, Itakura H, Ishikawa Y, Ouchi Y, Horibe H, Egashira T, Hattori H, Shirahashi N, and Kita T: Polymorphisms in four genes related to triglyceride and HDL-cholesterol levels in the general Japanese population in 2000. J Atheroscler Thromb, 2005; 12:240-250
15. Hallman DM, Boerwinkle E, Saha N, Sandholzer C, Menzel HJ, Csazar A, and Utermann G: The apolipoprotein E polymorphism: a comparison of allele frequencies and effects in nine populations. Am J Hum Genet, 1991; 49:338-349
16. Eto M, Watanabe K, and Ishii K: Reciprocal effects of apolipoprotein E alleles (epsilon 2 and epsilon 4) on plasma lipid levels in normolipidemic subjects. Clin Genet, 1986; 29:477-484
17. Kobori S, Nakamura N, Uzawa H, and Shichiri M: Influence of apolipoprotein E polymorphism on plasma lipid and apolipoprotein levels, and clinical characteristics of type III hyperlipoproteinemia due to apolipoprotein E phenotype E2/2 in Japan. Atherosclerosis, 1988; 69:81-88